Shire Mutual Funds | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | Shire PLC

Shire PLC | Mutual Funds

Mutual Funds that own Shire PLC

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

American Funds EuroPacific Growth Fund

30,862,350

3.38%

1,581,850

1.26%

06/30/2018

Government Pension Fund - Global (The)

20,894,044

2.29%

2,316,713

0.14%

12/31/2017

Vanguard Total International Stock Index Fund

10,402,135

1.13%

215,086

0.17%

07/31/2018

Harbor International Fund

6,784,224

0.74%

-5,813,374

1.75%

06/30/2018

iShares MSCI EAFE ETF

4,502,919

0.49%

0.37%

09/06/2018

Fidelity Funds SICAV - European Growth Fund

4,394,449

0.48%

-1,066,421

2.95%

05/31/2018

Vanguard Developed Markets Index Fund

3,877,273

0.42%

-3,256

0.21%

07/31/2018

BlackRock CIF - UK Equity Tracker Fund

3,875,879

0.42%

1.64%

01/31/2018

T Rowe Price International Stock Fund

3,190,350

0.35%

-1,372,551

1.25%

06/30/2018

Fidelity Invt. Funds - Special Situations Fund

3,177,890

0.35%

4.33%

12/31/2017

About Shire

View Profile

Address	4-1-1 Dosho-machi Osaka Osaka 540 Japan
Employees	-
Website	http://www.takeda.co.jp
Updated	07/08/2019
Shire Plc is a biopharmaceutical company. It engaged in the research, development, licensing, manufacturing, marketing, distribution and sale of medicines to meet significant unmet patient needs. The company's products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr and foznol.